Anbio Biotechnology (NASDAQ:NNNN) Trading Down 5.9% – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) shares dropped 5.9% on Monday . The stock traded as low as $7.40 and last traded at $7.2150. 5,122 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 59,382 shares. The stock had previously closed at $7.67.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

Anbio Biotechnology Trading Down 5.7%

The company has a fifty day simple moving average of $10.51 and a 200-day simple moving average of $20.02.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.